Delivery Order SPE2DB24D2010-SPE2DB25FAAYT
- Not listed
- On January 7, 2026, the Defense Logistics Agency awarded a $19,635 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes. This non-set-aside contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and extending through December 2026. The vaccine product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with a completion date...
- The Defense Logistics Agency awarded a $5,594.61 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of November 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML Vial 10ML vaccine product, with a ceiling value of $3,404.70. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by August 7, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $23,376.50 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on November 18, 2025, with an ultimate completion date of November 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,379.80 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. The contract represents a firm fixed price delivery order with an ultimate completion date of September 19, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $3,449.50 with a completion date of August 27, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award is issued as a child contract under...
- The Defense Logistics Agency awarded a $3,449 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, with a completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $3,614.20 with a completion date of November 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine product, reflecting the company's role in supplying...
- The Defense Logistics Agency awarded a delivery order valued at $1,379.80 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical supply transaction within the...
- The Defense Logistics Agency awarded a $13,645.30 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAYTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML vaccine in syringe form. This firm fixed-price delivery order, valued at $7,588.90, represents a non-set-aside, competitively awarded contract with an ultimate completion date of August 27, 2025. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, leverages this comprehensive IDC as a global pharmaceutical support vehicle to supply military healthcare systems and other federal agencies with vaccines, medications, and medical supplies across multiple therapeutic domains. As a child delivery order under this prime indefinite delivery vehicle, the TYPHIM VI award exemplifies the company's established capability to fulfill federal medical procurement requirements and support the Defense Health Agency's vaccine distribution needs for military personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 8/26/25 |